del.icio.us
OSI Plays Hard To Getpublished Mon, Mar 15 2010 16:40 GMT
Biotech rejects unsolicited $3 billion bid from Japan's Astellas Pharma, says it would entertain a higher offer.
Click for more articles from www.forbes.com
|
|